Followers | 142 |
Posts | 5891 |
Boards Moderated | 0 |
Alias Born | 10/27/2003 |
Friday, May 19, 2017 6:08:02 AM
As the majority owner of shares in MDMN, Auryn (and any majority owning entity for that matter) is entitled to have board appointments to make sure their interests are represented - just like MDMN, as a 27.5% owner in Auryn, has representation on Auryn's board.
Additionally, because of the fraud that Price perpetrated on MDMN, and arguably at the expense of Auryn and all other MDMN shareholders, it is doubly imperative for Auryn that it has sufficient board representation to protect its ownership interest given MDMN (albeit through no fault of their own) had already violated the contract.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM